InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by MORRISSEY MICHAEL, Chief Executive Officer. Director active across 1 companies, notably Exelixis, INC.. In total, 10 reports have been logged. The latest transaction was disclosed on 2 March 2022 — Don. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
050,000 shares0
Common Stock
SEC:0000939767-22-000039:0·
€100,3466,103 shares@ €16.44210.0009% mcap23.1% of flow
Common Stock
SEC:0000939767-22-000019:0·
0196,524 shares0
Common Stock
SEC:0000939767-21-000117·
0196,524 shares0
Common Stock
SEC:0000939767-21-000117:0·
€166,57810,530 shares@ €15.81940.0014% mcap100.0% of flow
Common Stock
SEC:0000939767-21-000101·
€166,57810,530 shares@ €15.81940.0014% mcap38.4% of flow
Common Stock
SEC:0000939767-21-000101:0·
094,002 shares0
Common Stock
SEC:0000939767-21-000091·
094,002 shares0
Common Stock
SEC:0000939767-21-000091:0·
040,616 shares0
Common Stock
SEC:0000939767-21-000051·
040,616 shares0
Common Stock
SEC:0000939767-21-000051:0·
10 of 10 declarations
About MORRISSEY MICHAEL
Michael Morrissey is the President and CEO of EXELIXIS, INC. In this role, he is responsible for the strategic and operational direction of the company. His experience in the biopharmaceutical sector is crucial for the development and growth of Exelixis.
